The following table presents information included in our Unaudited Condensed Consolidated Financial Statements related to our equity investees: | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended
September 30, | | Nine Months Ended
September 30, | | | 2025 | | 2024 | | 2025 | | 2024 | | Genesis’ share of operating earnings | $ | 14,411 | | | $ | 15,200 | | | $ | 46,365 | | | $ | 50,986 | | | Amortization of differences attributable to Genesis’ carrying value of equity investments | (3,566) | | | (3,566) | | | (10,698) | | | (10,698) | | | Equity in earnings of equity investees | $ | 10,845 | | | $ | 11,634 | | | $ | 35,667 | | | $ | 40,288 | | Distributions received(1) | $ | 16,078 | | | $ | 18,488 | | | $ | 52,587 | | | $ | 58,829 | |
|